Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment.
Philip M. Wallace(Bristol-Myers Squibb (United States)), Peter S. Linsley(Rosetta Stone (United States)), Jacob Rodgers(Bristol-Myers Squibb (United States)), Gina Leytze(Bristol-Myers Squibb (United States)), Jessica Johnson(University of North Carolina at Chapel Hill)
Cited by 69
Related Papers
De novo mutations in schizophrenia implicate synaptic networks
|Nature|2014|1.7k
CTLA-4 is a second receptor for the B cell activation antigen B7.
|The Journal of Experimental Medicine|1991|1.7k
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
Gene expression elucidates functional impact of polygenic risk for schizophrenia
|Nature Neuroscience|2016|1.2k